Rekt_but_not_broke

Silver's role in modern economy extends far beyond traditional jewelry and collectibles. The precious metal serves as a critical input across electronics, renewable energy infrastructure and automotive systems—a reality reflected in the Silver Institute's latest projections. Global consumption

Waste Management (WM) recently experienced a 1.08% decline, but has shown strong monthly growth. Anticipated earnings growth and solid industry positioning support a positive investment outlook, despite recent cautious analyst sentiment.

Major U.S. stock indices faced significant headwinds on the final trading day of 2025, with the S&P 500 falling -0.15%, the Dow Jones Industrials declining -0.18%, and the Nasdaq 100 dropping -0.19%. Futures markets echoed this weakness, with March E-mini S&P contracts down -0.17% and March E-mini N

SoftOx Solutions AS has gained approval for its Phase 2a trial of the SoftOx Inhalation Solution, leading to a 35.74% rise in stock price. This trial, targeting biofilm infections without antibiotics, signals a significant market opportunity, especially in cystic fibrosis and bronchiectasis. Key trial data is expected between 2026 and 2027, potentially shaping investor confidence.

A 600 credit score puts you in a tricky spot. Financial institutions view this number as a warning sign—they question whether you'll handle borrowed money responsibly. The reality? Doors close. Interest rates spike. Options shrink. But here's the encouraging part: this situation isn't permanent, and

SELLAS Life Sciences reported positive results in its Phase 3 REGAL trial for Galinpepimut-S, showing better-than-expected patient survival in acute myeloid leukemia. The study awaits further mortality events for final analysis, indicating potential for improved outcomes in a challenging patient group.

The economic clouds gathering on the horizon—elevated interest rates, lingering inflation pressures, and recent financial turbulence—paint a challenging picture for markets. Yet within this uncertainty lies opportunity, particularly in sectors positioned to benefit from structural long-term

As 2025 winds down toward its final trading sessions, U.S. equities continue to drift in tight ranges near all-time highs. The S&P 500 retreated 0.13% to 6,896.45, the Nasdaq Composite declined 0.24% to 23,419.08, and the Dow Jones Industrial Average fell 0.20% to 48,367.05 in subdued year-end tradi

Thinking about welcoming a four-legged companion into your home? Before you fall for those adorable puppy eyes, it's crucial to understand the financial commitment that comes with dog ownership. Beyond the initial adoption or purchase fee, you'll need to budget for healthcare, nutrition, and care th

The Comeback Challenge
Nike finds itself at a crossroads. After decades of dominance in athletic footwear and apparel, the company recently reported disappointing results that have left investors questioning its momentum. In fiscal 2025's fourth quarter, revenues contracted 12% year-over-year

HUTCHMED has received priority review for Fanregratinib's application targeting advanced intrahepatic cholangiocarcinoma, responding to a significant medical need. The drug's Phase 2 study showed promising efficacy. The company also has a diverse oncology portfolio and reported a revenue of $277.7 million for the first half of 2025, with strong financial resources for future developments.

When market turbulence strikes, dividend-paying investments stand out as reliable income generators. While aggressive growth strategies grab headlines, a growing number of investors are turning to a quieter but

Ralph Lauren's stock fell 1.41% amid broader market declines, with modest monthly gains. Upcoming earnings reports show optimistic projections, despite mixed analyst sentiment. Investors should watch for potential stock repricing ahead of the announcements.

Starbucks is executing a dramatic retreat from its once-dominant urban strategy, marking a pivotal shift in how the coffee chain approaches big-city retail. Under newly appointed Chief Executive Brian Niccol, the company is closing approximately 400 underperforming U.S. locations concentrated in

Michael Jordan has cemented his legacy not just on the basketball court, but in the wealth-building arena as well. With a net worth estimated at $3.8 billion as of 2025, he stands as the richest athlete in history and the only former NBA player to reach billionaire status. But here's the question th

The Contract for Difference (CFD) is a derivative that allows trading assets without owning them, incorporating leverage and margin. Its versatility spans various markets, enabling profits in both rising and falling markets with reduced costs. The operations are simple, based on price differences, allowing bets in multiple directions.

Ethereum is under mounting selling pressure as ETH trades near critical support levels, with the $3,000 zone emerging as the psychological battleground that will define the near-term direction. Currently priced around $3.13K, ETH has retreated from its recent highs and is now testing whether

While everyone's obsessing over flashy AI startups, the real money in 2026 will flow to the companies that actually build AI infrastructure. We're talking energy, chips, storage, and the physical backbone that keeps models running 24/7. Here's what actually matters—and what's just noise.
The

The Australian Dollar continues its downward trajectory, losing ground for the sixth consecutive session against the US Dollar despite mounting expectations for an imminent rate increase from the Reserve Bank of Australia. Market sentiment remains divided, with the weakness in AUD reflecting